The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

20 Dec 2023 11:06

RNS Number : 4799X
Panmure Gordon (UK) Limited
20 December 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Velocys plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Velocys plc

(d) Date dealing undertaken:

19 Dec 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

666,861

0.002285 GBP

0.002208 GBP

1p ordinary

Sales

7,536

0.002395 GBP

0.002395 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

20/12/2023

Contact name:

Freddie Wooding

Telephone number:

+44 (0)2078 862 969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZMZZMGKGFZM
Date   Source Headline
6th Sep 201812:02 pmRNSPrice Monitoring Extension
6th Sep 201811:07 amRNSStatement re Share Price Movement
15th Aug 20182:40 pmRNSHolding(s) in Company
13th Aug 20185:00 pmRNSTR-1: Notification of major holdings
13th Aug 201810:10 amRNSHolding(s) in Company
8th Aug 201812:26 pmRNSResult of general meeting and total voting rights
7th Aug 20187:00 amRNSEnvironmental milestone for Mississippi project
23rd Jul 20187:05 amRNSFund raise of £6 million
4th Jul 20187:00 amRNSENVIA plant update
3rd Jul 20182:54 pmRNSBlock listing Interim Review
29th Jun 201812:52 pmRNSResult of AGM
19th Jun 20187:00 amRNSVelocys and PQ partner for catalyst manufacturing
18th Jun 20187:00 amRNSDevelopment funding secured for UK project
5th Jun 20182:53 pmRNSMailing of 2017 annual report and AGM notice
23rd May 20187:00 amRNSFinal results for the year ended 31 December 2017
15th May 20187:00 amRNSENVIA plant update
4th May 20187:00 amRNSVelocys sells license to Red Rock Biofuels
17th Apr 20187:01 amRNSResponse to press coverage
15th Mar 20187:00 amRNSENVIA biorefinery - RINs verified
26th Feb 20181:37 pmRNSHolding(s) in Company
7th Feb 20187:00 amRNSDirectorate Change
6th Feb 20187:00 amRNSHolding(s) in Company
6th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
2nd Feb 201812:11 pmRNSDirector/PDMR Shareholding
31st Jan 20183:21 pmRNSResult of general meeting and total voting rights
16th Jan 20187:00 amRNSOklahoma City plant - RIN credit submission
15th Jan 20187:00 amRNSFund raise of approximately £18.4 million
3rd Jan 20185:20 pmRNSBlock listing Interim Review
1st Nov 201710:02 amRNSTotal Voting Rights
30th Oct 20177:00 amRNSOklahoma City plant on track for final capacity
20th Oct 20177:00 amRNSSite confirmed for first U.S. biorefinery
29th Sep 20177:00 amRNSInterim results for the 6 months ended 30 June 17
28th Sep 20179:49 amRNSChange of Registered Office
18th Sep 201710:00 amRNSPartnership formed, aimed at waste-to-jet-fuel
1st Aug 20179:37 amRNSTotal Voting Rights
21st Jul 20177:01 amRNSBusiness Update
21st Jul 20177:00 amRNSDirectorate Change
3rd Jul 20179:34 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSFirst finished product at ENVIA Energy's GTL plant
22nd Jun 20171:45 pmRNSResult of AGM
22nd Jun 20177:00 amRNSAGM Statement
19th Jun 20177:00 amRNSAdvancing towards U.S. Dept. of Agriculture Loan
16th Jun 20177:00 amRNSDirectorate Change
6th Jun 20171:29 pmRNSHolding(s) in Company
5th Jun 20177:00 amRNSSelection of IHI E&C for feasibility engineering
1st Jun 20173:14 pmRNSDirectorate Change
1st Jun 20171:58 pmRNSResult of General Meeting
26th May 201711:02 amRNSMailing of Annual Financial Report & AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.